BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boulter L, Bullock E, Mabruk Z, Brunton VG. The fibrotic and immune microenvironments as targetable drivers of metastasis. Br J Cancer 2021;124:27-36. [PMID: 33239677 DOI: 10.1038/s41416-020-01172-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Santolla MF, Talia M, Cirillo F, Scordamaglia D, De Rosis S, Spinelli A, Miglietta AM, Nardo B, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M. The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells. Cells 2022;11:2402. [DOI: 10.3390/cells11152402] [Reference Citation Analysis]
2 Yun H, Im HJ, Choe C, Roh S. Effect of LOXL2 on metastasis through remodeling of the cell surface matrix in non-small cell lung cancer cells. Gene 2022;830:146504. [PMID: 35483499 DOI: 10.1016/j.gene.2022.146504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kopchick JJ, Basu R, Berryman DE, Jorgensen JOL, Johannsson G, Puri V. Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer. Nat Rev Endocrinol 2022. [PMID: 35750929 DOI: 10.1038/s41574-022-00702-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Koshiishi M, Kawashima I, Hyuga H, Nakadate A, Matsuura M, Hosokawa E, Sakamoto Y, Suzuki J, Suzuki M, Kumagai T, Yamamoto T, Nakajima K, Tanaka M, Kirito K. Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease. Int J Hematol 2022. [PMID: 35538304 DOI: 10.1007/s12185-022-03373-1] [Reference Citation Analysis]
5 De Marco M, Gauttier V, Pengam S, Mary C, Ranieri B, Basile A, Festa M, Falco A, Reppucci F, Cammarota AL, Acernese F, De Laurenzi V, Sala G, Brongo S, Miyasaka M, Shalapour S, Vanhove B, Poirier N, Iaccarino R, Karin M, Turco MC, Rosati A, Marzullo L. Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth. Cell Death Discov 2022;8:94. [PMID: 35241649 DOI: 10.1038/s41420-022-00817-9] [Reference Citation Analysis]
6 Worsley CM, Veale RB, Mayne ES. The acidic tumour microenvironment: Manipulating the immune response to elicit escape. Hum Immunol 2022:S0198-8859(22)00030-1. [PMID: 35216847 DOI: 10.1016/j.humimm.2022.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Palano MT, Cucchiara M, Gallazzi M, Riccio F, Mortara L, Gensini GF, Spinetti G, Ambrosio G, Bruno A. When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors. Front Immunol 2021;12:798155. [PMID: 35095876 DOI: 10.3389/fimmu.2021.798155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sflomos G, Schipper K, Koorman T, Fitzpatrick A, Oesterreich S, Lee AV, Jonkers J, Brunton VG, Christgen M, Isacke C, Derksen PWB, Brisken C. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (Basel) 2021;13:5396. [PMID: 34771558 DOI: 10.3390/cancers13215396] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Deasy SK, Erez N. A glitch in the matrix: organ-specific matrisomes in metastatic niches. Trends Cell Biol 2021:S0962-8924(21)00162-8. [PMID: 34479765 DOI: 10.1016/j.tcb.2021.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
10 Zhao Y, Bilal M, Qindeel M, Khan MI, Dhama K, Iqbal HMN. Nanotechnology-based immunotherapies to combat cancer metastasis. Mol Biol Rep 2021;48:6563-80. [PMID: 34424444 DOI: 10.1007/s11033-021-06660-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Del Piccolo N, Shirure VS, Bi Y, Goedegebuure SP, Gholami S, Hughes CCW, Fields RC, George SC. Tumor-on-chip modeling of organ-specific cancer and metastasis. Adv Drug Deliv Rev 2021;175:113798. [PMID: 34015419 DOI: 10.1016/j.addr.2021.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 Schuler LA, Murdoch FE. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers. Cancers (Basel) 2021;13:3725. [PMID: 34359625 DOI: 10.3390/cancers13153725] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Chung JY, Chan MK, Li JS, Chan AS, Tang PC, Leung KT, To KF, Lan HY, Tang PM. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment. Int J Mol Sci 2021;22:7575. [PMID: 34299192 DOI: 10.3390/ijms22147575] [Cited by in F6Publishing: 30] [Reference Citation Analysis]
14 Fuqua SAW. Metastasis: complexity thwarts precision targeting. Br J Cancer 2021. [PMID: 34226682 DOI: 10.1038/s41416-021-01401-1] [Reference Citation Analysis]
15 Caballero D, Brancato V, Lima AC, Abreu CM, Neves NM, Correlo VM, Oliveira JM, Reis RL, Kundu SC. Tumor-Associated Protrusion Fluctuations as a Signature of Cancer Invasiveness. Adv Biol (Weinh) 2021;:e2101019. [PMID: 34218529 DOI: 10.1002/adbi.202101019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Peng L, Zhang Y, Wang Z. Immune Responses against Disseminated Tumor Cells. Cancers (Basel) 2021;13:2515. [PMID: 34063848 DOI: 10.3390/cancers13112515] [Cited by in F6Publishing: 1] [Reference Citation Analysis]